The OneChoice Report is a revolution in patient care. Dozens of factors such as organisms, resistance genes, drug sensitivity, diagnosis codes, patient age, antibiotic allergies, renal function, pregnancy and more are all combined to reach a unique targeted and evidence-based treatment plan for each patient.
OneChoice makes real-time, evidence-based medicine a reality.
Every report comes with easy access to an online version where you can delve deeper into the recommendations, access reference materials, translations, and additional dosing.
ArkScore™ helps prescribers make better-informed decisions by presenting complex information on a simple numerical scale. When faced with multiple patients, different lab results, and countless resistance genes, it can be difficult for prescribers to compare drug options or even the levels of infection complexity between patients.
The different ArkScore values combine Arkstone’s expertise in antimicrobial stewardship with complex algorithms and a deep understanding of infectious disease to help provide the most effective treatment, with the least risk for adverse events, reducing the unnecessary use of broad-spectrum antibiotics.
Arkstone does a great job of identifying pathogens and resistance to certain antibiotics, and we love the fact that the reports use a score to rank treatments that doctors can consider. The Arkstone Report assists our physicians in making wise decisions for antibiotic use and patient care.
Clinically, Arkstone has significantly decreased my time until optimal treatment. Thanks for your help saving limbs!
After following the Arkstone antibiotic treatment recommendation my patient's wound is healing, the small red area is gone, and the overall redness has decreased indicating the infection is gone.
The Arkstone Reports provide recommendations and infection control measures that have significantly improved the way we care for patients. It is truly a unique feature that will revamp our antimicrobial stewardship programs.
Successful wound healing requires expertise in the management of bioburdens, biofilms, and microbes. Arkstone's advanced input and patient-specific recommendations have translated to superior results in wound healing and patient satisfaction. This has led to better outcomes, unparalleled medical decision making, and respect among medical professionals in the mid-south.
When it comes to PCR, results can be complicated. Arkstone is a great clinical tool that can help physicians choose the right regimen for their patients.
Our providers are so happy we partnered with Arkstone as now they have in depth and actionable guidance with each lab result.
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
The first step in precision-guided patient care is determining which organisms detected in a lab result are most likely to be pathogenic, and therefore the highest value targets for treatment.
PathFinder™ uses proprietary algorithms, supervised machine learning and artificial intelligence to identify which organisms are more likely to be pathogenic and the cause of infection and the focus of the OneChoice treatment plans.
While a lab result may contain many detected organisms and resistance genes, their relevance can be different from sample to sample. For example, the same organism may be pathogenic if detected in a respiratory swab, but not in a urine sample. Likewise, certain detected resistance genes may not be relevant to the likely pathogens that need treatment, and therefore may not actually preclude certain treatment options.
The OneChoice Report and OneChoice Plus are intended to be used in conjunction.
The OneChoice Report is the provider’s inital source of information regarding the recommendations. But space on the page is limited, so expansive and interactive information and tools are available online via OneChoice PLUS.
Accessing OneChoice Plus is easy since each report includes a QR code link that will take clinicians directly to an online, interactive version of the report in their hands. OneChoice Plus allows clinicians to add or modify variables, like renal and hepatic function, allergies and pregnancy information, as well as accessing drug information, the MedsMatrix, literature references and NIH statistical data. The OneChoice Plus also has information pertaining to which resistance genes were tested for in a given sample, as well as information as to why an antibiotic may be precluded from use.
By using OneChoice Plus providers are able to make more informed decisions and get a broader understanding of the OneChoice recommendations.
OneChoice recommendations are based on published and accepted medical data. This includes Infectious Disease Society of America (IDSA) and the CDC guidelines. Antibiotic choices are based on intended use information on the FDA drug label.
Arkstone only references primary sources and does not rely on secondary sources such as treatment guides. The references used in determining treatment recommendations can be accessed via OneChoice Plus through the QR code on each report.
No. Research data has shown that infectious diseases physicians are the most qualified personnel for antimicrobial recommendations and stewardship. That’s why Arkstone uses human-in-the-loop machine learning, overseen by infectious disease clinicians and a highly trained multidisciplinary team, all of whom are licensed healthcare clinicians and prescribers.
Relying on pharmacists or other non-clinicians to make treatment recommendations can lead to mixed results for patients. Physicians are less likely to trust recommendations not made by a licensed practitioner. Additionally, non-clinicians lack the invaluable knowledge and experience that comes with treating patients in real world settings.
OneChoice is classified by the FDA as clinical decision support software (CDSS), intended to help prescribers make informed decisions.
Arkstone is not a laboratory. Arkstone analyzes data that laboratories obtain from specimens and is not involved in any of the processes the laboratory uses to determine if a specimen contains microbes or resistance genes.
Arkstone can work with any lab.
Arkstone integrates directly with laboratories through their laboratory information management system. Information is sent electronically to Arkstone after the laboratory has completely analyzed a specimen.